Stockreport

Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRaME-O1 Trial [Yahoo! Finance]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF – Planned 50 patients in Dose-Optimization (Part 1) of REFRaME-O1 have been enrolled and are in follow up – SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIR [Read more]